Evidence map›Paper›PMID 36322050›Full record

ArticleEMBO reports2023

The Toll pathway mediates Drosophila resilience to Aspergillus mycotoxins through specific Bomanins.

Rui Xu, Yanyan Lou, Antonin Tidu, Philippe Bulet, Thorsten Heinekamp, Franck Martin, Axel Brakhage, Zi Li, Samuel Liégeois, Dominique Ferrandon

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Gender-specific gene profiling inIBRO neuroscience reports · 2026
    Article
  4. Article
  5. Article
  6. α2-macroglobulin function of thioester-containing proteins guardsProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Frontiers in cellular and infection microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Rui Xu *Sino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, China.
Yanyan Lou *Sino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, China.ORCID 0000-0001-6899-7124
Antonin TiduUniversité de Strasbourg, Strasbourg, France.
Philippe BuletCR Université Grenoble Alpes, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Grenoble, France.ORCID 0000-0001-9016-265X
Thorsten HeinekampDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI), Jena, Germany.
Franck MartinUniversité de Strasbourg, Strasbourg, France.ORCID 0000-0001-9724-4025
Axel BrakhageDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI), Jena, Germany.
Zi LiSino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, China.
Samuel LiégeoisSino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, China.ORCID 0000-0003-3228-7678
Dominique FerrandonSino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, China.ORCID 0000-0001-7680-7773
Centre National de la Recherche Scientifique · FRLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEGuangzhou Medical University · CN

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
NIH HHS P40 OD018537
6 · The paper itself

Abstract

Host defense against infections encompasses both resistance, which targets microorganisms for neutralization or elimination, and resilience/disease tolerance, which allows the host to withstand/tolerate pathogens and repair damages. In Drosophila, the Toll signaling pathway is thought to mediate resistance against fungal infections by regulating the secretion of antimicrobial peptides, potentially including Bomanins. We find that Aspergillus fumigatus kills Drosophila Toll pathway mutants without invasion because its dissemination is blocked by melanization, suggesting a role for Toll in host defense distinct from resistance. We report that mutants affecting the Toll pathway or the 55C Bomanin locus are susceptible to the injection of two Aspergillus mycotoxins, restrictocin and verruculogen. The vulnerability of 55C deletion mutants to these mycotoxins is rescued by the overexpression of Bomanins specific to each challenge. Mechanistically, flies in which BomS6 is expressed in the nervous system exhibit an enhanced recovery from the tremors induced by injected verruculogen and display improved survival. Thus, innate immunity also protects the host against the action of microbial toxins through secreted peptides and thereby increases its resilience to infection.

Indexed as

Drosophila ProteinsMycotoxinsAnimalsAspergillusDrosophilaDrosophila melanogasterImmunity, InnateDrosophila ProteinsMycotoxinsDrosophila melanogasterfumitremorgin/verruculogenfungal infectionsresilience/disease tolerancerestrictocin

Identifiers

PMID36322050
PMCPMC9827548
OpenAlexW4307969869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.